Table 5– Test performed at diagnosis by age groups
Patient ageAll patientsp-value#
3≤24 months2–6 years7–11 years12–18 years
Patients N94134108118456
ECG90 (96)127 (95)102 (94)111 (94)430 (94)0.42
Chest radiograph87 (93)115 (86)94 (87)110 (93)406 (89)0.02
Echocardiogram88 (94)129 (96)106 (98)116 (98)439 (96)0.58
HC+91 (97)132 (99)103 (95)117 (99)445 (98)0.25
Holter monitor9 (10)26 (19)21 (19)38 (32)94 (21)0.001
Laboratory function tests78 (83)117 (87)103 (95)113 (96)411 (90)0.002
6-min walk test§032 (24)59 (55)84 (71)175 (38)<0.001
Cardiopulmonary exercise test03 (2)12 (11)19 (16)34 (7)<0.001
Pulmonary function tests2 (2)16 (12)40 (37)64 (54)122 (27)<0.001
Overnight oxygen saturation and sleep recording31 (33)45 (34)23 (21)30 (25)129 (28)0.10
Lung perfusion scintigraphy11 (12)27 (20)28 (26)38 (32)104 (23)0.004
Pulmonary angiography42 (45)61 (46)45 (42)50 (42)198 (43)0.89
Chest computed tomography36 (38)53 (40)46 (43)54 (46)189 (41)0.70
Magnetic resonance imaging1 (1)4 (3)13 (12)24 (20)42 (9)<0.001
Lung biopsy5 (5)8 (6)4 (4)4 (3)21 (5)0.75
  • Data are presented as n (%) unless otherwise stated. N: total number of patients; n: all patients who were confirmed as having undergone the procedure. HC: heart catheterisation. #: Fisher's exact test to compare across the age groups for diagnostic procedure being performed; : the exact date of birth could not be obtained for two patients; however, both were in the paediatric age group and included in the general analysis and do not appear in this table; + it was intended that all patients would undergo HC; however, 11 patients had indications on their case-report form that pulmonary hypertension was not confirmed by HC, 10 patients provided no further HC data. §: nine of these patients (2–6 years n = 2; 7–11 years n = 1; 12–8 years n = 6) have Down syndrome or other chromosomal abnormalities. The denominator for percentages was N.